These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

754 related items for PubMed ID: 33951569

  • 21. Honokiol regulates endoplasmic reticulum stress by promoting the activation of the sirtuin 1-mediated protein kinase B pathway and ameliorates high glucose/high fat-induced dysfunction in human umbilical vein endothelial cells.
    Ye H, Meng Y.
    Endocr J; 2021 Aug 28; 68(8):981-992. PubMed ID: 33952780
    [Abstract] [Full Text] [Related]

  • 22. Suppression of Apoptosis in Human Umbilical Vein Endothelial Cells (HUVECs) by Klotho Protein is Associated with Reduced Endoplasmic Reticulum Oxidative Stress and Activation of the PI3K/AKT Pathway.
    Cui W, Leng B, Liu W, Wang G.
    Med Sci Monit; 2018 Nov 24; 24():8489-8499. PubMed ID: 30471224
    [Abstract] [Full Text] [Related]

  • 23. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
    Jung KH, Choi MJ, Hong S, Lee H, Hong SW, Zheng HM, Lee HS, Hong S, Hong SS.
    Cancer Lett; 2012 Mar 28; 316(2):187-95. PubMed ID: 22182943
    [Abstract] [Full Text] [Related]

  • 24. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
    Zhao Z, Li C, Xi H, Gao Y, Xu D.
    Mol Med Rep; 2015 Oct 28; 12(4):5415-22. PubMed ID: 26166196
    [Abstract] [Full Text] [Related]

  • 25. Cucurbitacin E shows synergistic effect with sorafenib by inducing apoptosis in hepatocellular carcinoma cells and regulates Jak/Stat3, ERK/MAPK, PI3K/Akt/mTOR signaling pathways.
    Üremiş MM, Üremiş N, Türköz Y.
    Steroids; 2023 Oct 28; 198():109261. PubMed ID: 37355001
    [Abstract] [Full Text] [Related]

  • 26. Endoplasmic reticulum stress-induced resistance to doxorubicin is reversed by paeonol treatment in human hepatocellular carcinoma cells.
    Fan L, Song B, Sun G, Ma T, Zhong F, Wei W.
    PLoS One; 2013 Oct 28; 8(5):e62627. PubMed ID: 23658755
    [Abstract] [Full Text] [Related]

  • 27. Triterpenoid pristimerin induced HepG2 cells apoptosis through ROS-mediated mitochondrial dysfunction.
    Guo Y, Zhang W, Yan YY, Ma CG, Wang X, Wang C, Zhao JL.
    J BUON; 2013 Oct 28; 18(2):477-85. PubMed ID: 23818365
    [Abstract] [Full Text] [Related]

  • 28. Treatment with a New Barbituric Acid Derivative Exerts Antiproliferative and Antimigratory Effects against Sorafenib Resistance in Hepatocellular Carcinoma.
    Liao YJ, Hsu SM, Chien CY, Wang YH, Hsu MH, Suk FM.
    Molecules; 2020 Jun 20; 25(12):. PubMed ID: 32575795
    [Abstract] [Full Text] [Related]

  • 29. Protein phosphatase 2A-B55β mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling.
    Qian B, Che L, Du ZB, Guo NJ, Wu XM, Yang L, Zheng ZX, Gao YL, Wang MZ, Chen XX, Xu L, Zhou ZJ, Lin YC, Lin ZN.
    Theranostics; 2023 Jun 20; 13(12):4288-4302. PubMed ID: 37554285
    [Abstract] [Full Text] [Related]

  • 30. 9-bis[2-(pyrrolidin-1-yl)ethoxy]-6-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-11H-indeno[1, 2-c]quinolin-11-one (BPIQ), A Quinoline Derivative Inhibits Human Hepatocellular Carcinoma Cells by Inducing ER Stress and Apoptosis.
    Chang WT, Fong Y, Chuang SC, Chou CK, Chou HL, Yang CF, Tseng CH, Chen YL, Chiu CC.
    Anticancer Agents Med Chem; 2017 Jun 20; 17(5):692-700. PubMed ID: 27491935
    [Abstract] [Full Text] [Related]

  • 31. Neferine isolated from Nelumbo nucifera enhances anti-cancer activities in Hep3B cells: molecular mechanisms of cell cycle arrest, ER stress induced apoptosis and anti-angiogenic response.
    Yoon JS, Kim HM, Yadunandam AK, Kim NH, Jung HA, Choi JS, Kim CY, Kim GD.
    Phytomedicine; 2013 Aug 15; 20(11):1013-22. PubMed ID: 23746959
    [Abstract] [Full Text] [Related]

  • 32. Sorafenib and CuB exert synergistic antitumor effects against hepatocellular carcinoma cells via inhibition of STAT3 phosphorylation.
    Wang X, Li H, Li D, Bai Y, Zhang Y, Yan X, Li J, Zhao R, Liu J, Liu W, Shi M, Xu C, Yang T, Zhang T.
    FEBS Open Bio; 2021 Jan 15; 11(1):133-145. PubMed ID: 33176070
    [Abstract] [Full Text] [Related]

  • 33. Melatonin Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib through the PERK-ATF4-Beclin1 Pathway.
    Zhou B, Lu Q, Liu J, Fan L, Wang Y, Wei W, Wang H, Sun G.
    Int J Biol Sci; 2019 Jan 15; 15(9):1905-1920. PubMed ID: 31523192
    [Abstract] [Full Text] [Related]

  • 34. Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress.
    Shen Z, Yin L, Zhou H, Ji X, Jiang C, Zhu X, He X.
    Cell Oncol (Dordr); 2021 Oct 15; 44(5):1035-1049. PubMed ID: 34176092
    [Abstract] [Full Text] [Related]

  • 35. KIAA1429 mediates epithelial mesenchymal transition in sorafenib-resistant hepatocellular carcinoma through m6A methylation modification.
    Kuang Y, Cheng Y, Wang J, Li H, Cao X, Wang Y.
    Cancer Med; 2023 Mar 15; 12(6):7222-7233. PubMed ID: 36420693
    [Abstract] [Full Text] [Related]

  • 36. Carvacrol enhances anti-tumor activity and mitigates cardiotoxicity of sorafenib in thioacetamide-induced hepatocellular carcinoma model through inhibiting TRPM7.
    Yousef EH, Abo El-Magd NF, El Gayar AM.
    Life Sci; 2023 Jul 01; 324():121735. PubMed ID: 37142088
    [Abstract] [Full Text] [Related]

  • 37. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
    Zheng N, Liu W, Li B, Nie H, Liu J, Cheng Y, Wang J, Dong H, Jia L.
    J Exp Clin Cancer Res; 2019 May 31; 38(1):232. PubMed ID: 31151472
    [Abstract] [Full Text] [Related]

  • 38. Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro.
    Qu Z, Wu J, Wu J, Luo D, Jiang C, Ding Y.
    J Exp Clin Cancer Res; 2016 Sep 30; 35(1):159. PubMed ID: 27716356
    [Abstract] [Full Text] [Related]

  • 39. Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling.
    Fan C, Zheng W, Fu X, Li X, Wong YS, Chen T.
    Oncotarget; 2014 May 15; 5(9):2853-63. PubMed ID: 24797310
    [Abstract] [Full Text] [Related]

  • 40. Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation.
    Zhai B, Jiang X, He C, Zhao D, Ma L, Xu L, Jiang H, Sun X.
    Tumour Biol; 2015 Apr 15; 36(4):2323-34. PubMed ID: 25416439
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.